Arsenic Trioxide Suppresses Growth of BCR-ABL1 Positive Cells with "Gatekeeper" or Compound Mutation

被引：0
|
作者：
Mian, Afsar Ali [1 ]
Raees, Hadiqa [1 ]
Ahmad, Sujjawal [1 ]
Ottmann, Oliver [2 ]
Lalani, El-Nasir M. A. [1 ]
机构：
[1] Aga Khan Univ, Ctr Regenerat Med & Stem Cell Res, Karachi, Pakistan
[2] Cardiff Univ, Sch Med, Div Canc & Genet, Dept Haematol, Cardiff, Wales
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-154511
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4346
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation
    Xia, Daniel
    Hsi, Eric D.
    Dal Cin, Paola
    Hasserjian, Robert P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (04) : 504 - 505
  • [42] Inhibition Of PI3K/mTOR Overcomes Nilotinib Resistance In BCR-ABL1 Positive Leukemia Cells
    Ding, Jie
    Romani, Julia
    Zaborski, Margarete
    MacLeod, Roderick A. F.
    Nagel, Stefan
    Drexler, Hans G.
    Quentmeier, Hilmar
    BLOOD, 2013, 122 (21)
  • [43] Significance of RUNX1 mutation in BCR-ABL1 positive acute myeloid leukemia - a diagnostic dilemma in a young woman with persistent bleeding
    Ghosh, Sharmila
    Roth, Jacquelyn
    Babushok, Daria
    Lim, Megan
    LEUKEMIA & LYMPHOMA, 2022, 63 (08) : 1975 - 1979
  • [44] Ikzf1 haploinsufficiency contributes to the pathogenesis of BCR-ABL1 positive acute lymphoblastic leukemia
    Collins-Underwood, J. Racquel
    Miller, Christopher
    Downing, James
    Mullighan, Charles
    CANCER RESEARCH, 2009, 69
  • [45] THE STEMNESS INHIBITOR, BBI608, REDUCES THE SELF-RENEWAL OF BCR-ABL1 POSITIVE LEUKEMIA CELLS
    Tauchi, T.
    Okabe, S.
    Katagiri, S.
    Ohyashiki, K.
    HAEMATOLOGICA, 2015, 100 : 28 - 28
  • [46] IMATINIB INDUCES MARKED UPREGULATION OF RECOMBINATION ACTIVATING GENE (RAG) EXPRESSION IN BCR-ABL1 POSITIVE LYMPHOID CELLS
    Shahrin, Nur Hezrin
    Thomson, Daniel
    Wadham, Carol
    Schreiber, Andreas
    Branford, Susan
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S85 - S85
  • [47] SEQUENTIAL ACQUISITION OF BCR-ABL1 FUSION AND IKAROS DELETION IN PHILADELPHIA CHROMOSOME POSITIVE ALL
    Cazzaniga, Giovanni
    Van Delft, Frederik W.
    Colman, Sue
    Score, Joannah
    Kempski, Helena
    Taj, Mary
    Ford, Anthony
    Biondi, Andrea
    Greaves, Mel
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 833 - 833
  • [48] Identification Of FOXM1 As Therapeutic Target In BCR-ABL1 Positive Acute Lymphoblastic Leukemia
    Buchner, Maike
    Park, Eugene
    Klemm, Lars
    Geng, Huimin
    Kopanja, Dragana
    Raychaudhuri, Pradip
    Muschen, Markus
    BLOOD, 2013, 122 (21)
  • [49] INHIBITION OF PI3K/MTOR OVERCOMES NILOTINIB RESISTANCE IN BCR-ABL1 POSITIVE LEUKEMIA CELLS
    Ding, J.
    Romani, J.
    Zaborski, M.
    Nagel, S.
    Drexler, H.
    Quentmeier, H.
    HAEMATOLOGICA, 2013, 98 : 402 - 403
  • [50] ASSESSMENT OF THE MOLECULAR DISEASE LEVEL IN PATIENTS WITH BCR-ABL1 POSITIVE CML IN DENMARK AND ICELAND
    Pallisgaard, N.
    Udby, L.
    Dufva, I. H.
    Severinsen, M. T.
    Bjerrum, O. W.
    Bergmann, O. J.
    Starklint, J.
    Ronnov-Jessen, D.
    Reykdal, S.
    Stentoft, J.
    HAEMATOLOGICA, 2016, 101 : 740 - 740
12345